term1 stringlengths 1 2.45k | term2 stringlengths 1 2.45k |
|---|---|
bortezomib 3.5 mg INJECTION VIAL (EA) | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INJECTION VIAL (EA) | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INJECTION VIAL (EA) | BORTEZOMIB 3.5MG/VIL INJ |
bortezomib 3.5 mg INJECTION VIAL (EA) | Bortezomib 3.5mg Powder for solution for injection |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib 3.5 mg INTRAVEN VIAL (EA) |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib@3.5 mg@INTRAVEN@VIAL (EA) |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB (EQV-VELCADE) 3.5MG/VIL INJ |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg powder for solution for injection vial |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 1 mg in 1 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg in 3.5 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg in 3.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg in 3.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg in 3.5 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib 3.5 mg intravenous powder for injection |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib, 3.5 mg intravenous powder for injection |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | BORTEZOMIB 3.5MG/VIL INJ |
bortezomib@3.5 mg@INJECTION@VIAL (EA) | Bortezomib 3.5mg Powder for solution for injection |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib 3.5 mg INTRAVEN VIAL (EA) |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib@3.5 mg@INTRAVEN@VIAL (EA) |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB (EQV-VELCADE) 3.5MG/VIL INJ |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg powder for solution for injection vial |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 1 mg in 1 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg in 3.5 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg in 3.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg in 3.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg in 3.5 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib 3.5 mg intravenous powder for injection |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib, 3.5 mg intravenous powder for injection |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BORTEZOMIB 3.5MG/VIL INJ |
BORTEZOMIB 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Bortezomib 3.5mg Powder for solution for injection |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | bortezomib@3.5 mg@INTRAVEN@VIAL (EA) |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB (EQV-VELCADE) 3.5MG/VIL INJ |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg powder for solution for injection vial |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 1 mg in 1 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | bortezomib 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg in 3.5 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg in 3.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg in 3.5 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg in 3.5 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | bortezomib 3.5 mg intravenous powder for injection |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib, 3.5 mg intravenous powder for injection |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | BORTEZOMIB 3.5MG/VIL INJ |
bortezomib 3.5 mg INTRAVEN VIAL (EA) | Bortezomib 3.5mg Powder for solution for injection |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | BORTEZOMIB (EQV-VELCADE) 3.5MG/VIL INJ |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | Bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | bortezomib 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bortezomib] |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | BORTEZOMIB 3.5 mg INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [bortezomib] |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | Bortezomib 3.5 mg powder for solution for injection vial |
bortezomib@3.5 mg@INTRAVEN@VIAL (EA) | BORTEZOMIB 3.5 mg SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BORTEZOMIB] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.